Associations Between Lymphangioma And Chromosomal Abnormalities (E.g., Turner Syndrome)
Published on: July 10, 2025
Associations Between Lymphangioma And Chromosomal Abnormalities (E.g., Turner Syndrome)
Article author photo

Isabella Vozza

Bsc, Genetics, University College Dublin

Article reviewer photo

Asma Jama

Physician associate MSc QMUL

Introduction

Research has found that certain rare growths, such as lymphangiomas, can signal underlying genetic conditions, including Turner syndrome.1 Lymphangiomas are benign malformations of the lymphatic system; they often present as fluid-filled masses under the skin.2 Usually, they are harmless; their presence in some locations can point to chromosomal abnormalities.

This article examines the relationship between lymphangiomas and genetic disorders, such as Turner syndrome. By understanding the links, patients and healthcare providers can boost early detection and personalised treatment.

Overall, it is important to understand the key information:

  • What lymphangiomas are and how they develop
  • Chromosomal abnormalities and Turner syndrome
  • The association between lymphangiomas and genetic conditions
  • Implications for diagnosis and management

The takeaways from research on lymphangiomas go beyond their physical presence, as they can serve as important diagnostic tools for more serious genetic disorders. 

What is a lymphangioma?

A lymphangioma is a noncancerous (benign) malformation of the lymphatic system.2 Abnormal clusters of lymphatic vessels form soft, fluid-filled sacs or cysts. The growths are more commonly found in infants and young children, and can often be present at birth.2

The body has a complex lymphatic system, which is a network of constantly flowing lymph (clear fluid, containing white blood cells) through the bloodstream and tissues.3 The system helps with normal immune function and keeps fluid in the body balanced.2 Sometimes the flow becomes backed up and can pool in unwanted areas, forming cysts. These cysts can be small or very large lymphangiomas, depending on the blockage.

Common locations are: the neck (where they are called cystic hygromas)2, armpits, groin and abdomen. These growths develop due to a developmental error during foetal growth. The lymphatic vessels fail to properly drain or connect, leading to fluid buildup.

Lymphangiomas are a symptom of a traffic jam in the body’s drainage system, when lymph cannot flow properly. Their presence makes further medical evaluation important, despite them usually being painless and non-cancerous.

What causes lymphangiomas?

Lymphangiomas are broadly categorised into sporadic cases and syndromic cases. Sporadic cases are isolated incidents that are usually not genetic. Syndromic cases are more likely to be caused by underlying genetic conditions or mutations.

Congenital causes

Most lymphangiomas are formed during foetal development. The leading theories suggest that they occur due to:

  • Failed lymphatic system maturation, and malformed channels4
  • Abnormal budding  or clusters of lymphatic tissues, or misguided growth, also known as malformations4
  • Genetic mutations, often tied to conditions like Turner syndrome, Noonan syndrome, or Down syndrome4

Other causes (Rare)

Lymphangiomas can develop in adults due to trauma or surgery, chronic infections, or even cancer radiation therapy.4 These lymphangiomas are most often not the result of genetic mutations and can be treated by medical professionals when they arise.

Understanding chromosomal abnormalities

All of our DNA molecules are contained within strand-like structures called chromosomes. Each cell nucleus contains a set of chromosomes - there are 46 chromosomes organised into 23 sets in human cells.5 The DNA material is continually copied and replicated as new cells form; this process is especially important in foetal development.5

Mistakes can happen in the chromosomal replication process, where portions (or sometimes entire chromosomes) can be changed or missing from the set in newly formed cells. Abnormalities in chromosome number (either too many or too few) are known as aneuploidy

Common types of chromosomal abnormalities in humans include:

  • Monosomy (e.g. Turner syndrome)
  • Trisomy (e.g. Down syndrome)

Abnormalities in our chromosomes can cause genetic disruptions that interfere with normal development. These can lead to structural differences in the body, such as distinct facial features, heart defects or skeletal abnormalities. Sometimes developmental delays in motor skills, speech, and cognition also appear.5 The severity of these differences depends on the extent of the chromosomal abnormality - the changes can be minor or very extreme. 

What is turner syndrome?

Turner syndrome is a rare genetic disorder associated with a missing X chromosome. The condition usually affects people assigned female at birth. The small genetic difference leads to a wide range of physical and developmental differences.

Key features of turner syndrome

  • Short stature - most girls with Turner syndrome are shorter than average6
  • Webbed neck - some patients have extra skin around the neck, as well as a low hairline, or swollen hands/feet at birth6
  • Heart and Kidney issues - up to 50% of sufferers have heart defects, and many experience kidney problems6
  • Infertility - because of the missing chromosome, ovaries often don't develop properly, leading to early menopause

How is it diagnosed?

  • Before birth: It is detected  via ultrasound (shows kidney/heart issues) or prenatal genetic testing, the most common being NIPT testing6,7
  • In childhood, Doctors can suspect Turner syndrome due to slow growth rate, delayed puberty or physical features7
    • Karyotype test: shows a complete view of present and missing chromosomes, confirms diagnosis with a blood sample.6,7

It is important to note that every case of Turner Syndrome is different; some patients have mild symptoms and may not be diagnosed until adolescence, and others have more severe symptoms early on.7 Early treatment, like growth hormones, heart monitoring, and hormone therapy, can make a big difference in quality of life.

How are lymphangiomas linked to turner syndrome?

One of the most prominent signs of Turner syndrome is a cystic hygroma, a type of lymphangioma. 

Some of the ways that cystic hygromas are linked to the syndrome include:

  • The clinical presentation of large cystic hygromas, often seen as fluid-filled neck masses on ultrasound,   is a sign of Turner syndrome before birth8
  • In Turner syndrome, missing X chromosome genes disrupt lymphatic vessel development, causing fluid to accumulate in the neck or other areas8, 9
  • Detection of a cystic hygroma frequently leads to karyotype testing, confirming Turner syndrome early9

Diagnosis and testing of lymphangiomas

Prenatal detection

  • Ultrasound - Identifies cystic hygroma in fetal development15

Postnatal evaluation

  • Imaging (MRI, ultrasound) - Confirms lymphangioma size and location15
  • Biopsy - Rarely needed unless malignancy (cancer) is suspected
  • Genetic Testing - Karyotyping, microarray, or NIPT helps detect underlying chromosomal conditions15

Collaboration among geneticists, paediatricians, and surgeons ensures comprehensive care. 

Why it matters

  • Early intervention - Identifying a hygroma prompts monitoring for heart defects (like coarctation of the aorta) and kidney issues, common in Turner syndrome9
  • Outcomes vary - Some hygromas resolve before birth, while others may need postnatal treatment (e.g., surgery or sclerotherapy).

Did you know? Up to 70% of fetuses with a cystic hygroma and hydrops (fluid buildup) have Turner syndrome.10 This makes it a useful diagnostic clue.

Other chromosomal conditions associated with lymphangiomas

Not all lymphangiomas indicate Turner syndrome - this is why full genetic testing is vital for accurate diagnosis. Other conditions associated with lymphangiomas include:

  • Trisomy 21 (Down syndrome) - An increased risk of cystic hygromas and lymphatic problems is often observed11
  • Trisomy 18 (Edwards syndrome)  can be associated with fetal cystic hygromas11
  • Noonan syndrome is  a genetic (non-chromosomal) disorder that mimics the symptoms of Turner Syndrome,  such as the presentation of lymphangiomas11

Living with turner syndrome

Turner syndrome requires lifelong management, but proper care can allow many individuals to lead healthy lives. Early diagnosis and personalised medical care significantly improve outcomes.7 The key aspects of long-term care include:

  • Hormone therapy (oestrogen/progesterone) to support puberty and bone health7
  • Reproductive healthcare, sometimes including fertility preservation options7
  • Cardiac and metabolic monitoring to manage possible risks7
  • Psychological support to manage self-esteem, social, and emotional challenges7

Emerging diagnostic tools and future directions

New modern research is exploring liquid biopsies to detect lymphatic-associated genetic abnormalities through maternal blood samples - this could improve the prenatal diagnosis of Turner syndrome and other conditions.12 Scientists are also investigating targeted drug therapies (like mTOR inhibitors) to shrink lymphangiomas without surgery, particularly in syndromic cases.13 AI-assisted ultrasound analysis is also being tested to predict chromosomal abnormalities earlier than standard nuchal translucency measurements.14 These developments could change how we link lymphatic markers to genetic disorders and move towards predictive personalised interventions.

Summary

Lymphangiomas are non-cancerous growths; they can be important warning signs for chromosomal conditions like Turner syndrome. Modern research confirms that early genetic testing and imaging improve long-term outcomes and diagnosis. Recognising the connection between seemingly harmless symptoms and genetic conditions can empower patients and healthcare teams to pursue personalised care and proactive management of genetic conditions.

References

  1. Perry HD, Cossari AJ. Chronic lymphangiectasis in Turner’s syndrome. British Journal of Ophthalmology [Internet]. 1986 [cited 2025 Jun 15]; 70(5):396–9. Available from: https://bjo.bmj.com/content/70/5/396.
  2. Lymphangioma, Lymphatic Malformations Causes & Pictures. Cleveland Clinic [Internet]. [cited 2025 Jun 15]. Available from: https://my.clevelandclinic.org/health/diseases/23141-lymphangioma.
  3. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymph [Internet]. 2011 [cited 2025 Jun 15]. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymph.
  4. Wiegand S, Eivazi B, Barth PJ, Rautenfeld DB von, Folz BJ, Mandic R, et al. Pathogenesis of lymphangiomas. Virchows Arch [Internet]. 2008 [cited 2025 Jun 15]; 453(1):1–8. Available from: https://doi.org/10.1007/s00428-008-0611-z.
  5. Queremel Milani DA, Tadi P. Genetics, Chromosome Abnormalities. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jun 17]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK557691/.
  6. A genetic disorder that affects females-Turner syndrome - Symptoms & causes. Mayo Clinic [Internet]. [cited 2025 Jun 17]. Available from: https://www.mayoclinic.org/diseases-conditions/turner-syndrome/symptoms-causes/syc-20360782.
  7. Turner syndrome. nhs.uk [Internet]. 2018 [cited 2025 Jun 17]. Available from: https://www.nhs.uk/conditions/turner-syndrome/.
  8. Radhakrishnan K, Rockson SG. The Clinical Spectrum of Lymphatic Disease. Annals of the New York Academy of Sciences [Internet]. 2008 [cited 2025 Jun 17]; 1131(1):155–84. Available from: https://nyaspubs.onlinelibrary.wiley.com/doi/10.1196/annals.1413.015.
  9. Atton G, Gordon K, Brice G, Keeley V, Riches K, Ostergaard P, et al. The lymphatic phenotype in Turner syndrome: an evaluation of nineteen patients and literature review. Eur J Hum Genet [Internet]. 2015 [cited 2025 Jun 17]; 23(12):1634–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486366/.
  10. Obeidi N, Russell N, Higgins JR, O’Donoghue K. The Natural History of Anencephaly. Prenatal Diagnosis [Internet]. 2010 [cited 2025 Jun 17]; 30(4):357–60. Available from: https://obgyn.onlinelibrary.wiley.com/doi/10.1002/pd.2490.
  11. Miceli A, Stewart KM. Lymphangioma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jun 18]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK470333/.
  12. Heidrich I, Ačkar L, Mossahebi Mohammadi P, Pantel K. Liquid biopsies: Potential and challenges. Intl Journal of Cancer [Internet]. 2021 [cited 2025 Jun 18]; 148(3):528–45. Available from: https://onlinelibrary.wiley.com/doi/10.1002/ijc.33217.
  13. Wiegand S, Wichmann G, Dietz A. Treatment of Lymphatic Malformations with the mTOR Inhibitor Sirolimus: A Systematic Review. Lymphatic Research and Biology [Internet]. 2018 [cited 2025 Jun 18]; 16(4):330–9. Available from: http://www.liebertpub.com/doi/10.1089/lrb.2017.0062.
  14. He F, Wang Y, Xiu Y, Zhang Y, Chen L. Artificial Intelligence in Prenatal Ultrasound Diagnosis. Front Med [Internet]. 2021 [cited 2025 Jun 18]; 8. Available from: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2021.729978/full.
  15. The Fetal Medicine Foundation [Internet]. [cited 2025 Jun 18]. Available from: https://fetalmedicine.org/education/fetal-abnormalities/neck/cystic-hygroma.

Share

Isabella Vozza

Bsc, Genetics, University College Dublin

arrow-right